Abstract
Background: Cystic fibrosis (CF) is a genetic disorder that affects not only pulmonary function, but also multiple organ systems. The flow-mediated dilation (FMD) test is a non-invasive assessment of endothelial function and nitric oxide bioavailability. Thus, the purpose of this study was to determine if 1) endothelial dysfunction is present in young patients with CF, and 2) endothelial function is associated with pulmonary function and exercise capacity.Methods: 15 patients with CF and 15 demographically matched controls participated in this study. Spirometry, brachial artery FMD, and a maximal exercise capacity test on a cycle ergometer were performed on all subjects to determine pulmonary function, endothelial function, and exercise capacity, respectively.Results: No differences (p>0.05) in age, height, or BMI were observed between patients withCF and controls. FEV1 (% predicted), FEV1/FVC, and FEF25-75 were lower in patients with CF.VO2 peak (absolute and relative) was similar between groups; however, VO2 (% predicted andml/kg fat free mass/min) and peak workload were significantly (p
| Original language | English |
|---|---|
| Pages (from-to) | 939-946 |
| Journal | Chest |
| Volume | 143 |
| Issue number | 4 |
| Publication status | Published (in print/issue) - Apr 2013 |
Bibliographical note
Reference text: 1. Green D. Point: Flow-mediated dilation does reflect nitric oxide-mediated endothelial function. J Appl Physiol 2005;99:1233-1234; discussion 1237-12382. Uehata A, Lieberman EH, Gerhard MD, et al. Noninvasive assessment of endotheliumdependent
flow-mediated dilation of the brachial artery. Vascular Medicine 1997;2:87-92
3. Celermajer DS, Sorensen KE, Gooch VM, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992;340:1111-1115
4. Peinado VI, Barbera JA, Ramirez J, et al. Endothelial dysfunction in pulmonary arteries of patients with mild COPD. Am J Physiol 1998;274:L908-913
5. Johnstone MT, Creager MA, Scales KM. Impaired endothelium-dependent vasodilation in patients with insuline-dependent diabetes mellitus. Circulation 1993;88:2510-2516
6. Maiorana A, O'Droscoll F, Taylor R, Green D. Exercise and the Nitric Oxide Vasodilator System. Sports Med 2003;33:1013-1035
7. Edwards DG, Schofield RS, Lennon SL, et al. Effect of exercise training on endothelial function in men with coronary artery disease. Am J Cardiol 2004;93:617-620
8. Guerci B, Kearney-Schwartz A, Bohme P, Zannad F, Drouin P. Endothelial dysfunction and type 2 diabetes. Part 1: physiology and methods for exploring the endothelial function. Diabetes Metab 2001;27:425-434
9. Wolff B, Lodziewski S, Bollmann T, Opitz CF, Ewert R. Impaired peripheral endothelial function in severe idiopathic pulmonary hypertension correlates with the pulmonary vascular response to inhaled iloprost. Am Heart J 2007;153:1088 e1081-1087
10. Dinh Xuan AT, Higenbottam TW, Pepke-Zaba J, Clelland C, Wallwork J. Reduced
endothelium-dependent relaxation of cystic fibrosis pulmonary arteries. Eur J Pharmacol 1989;163:401-403
11. Henno P, Maurey C, Danel C, et al. Pulmonary vascular dysfunction in end-stage cystic fibrosis: role of NF-kappaB and endothelin-1. Eur Respir J 2009;34:1329-1337
12. Romano M, Collura M, Lapichino L, et al. Endothelial perturbation in cystic fibrosis. Thromb Haemost 2001;86:1363-1367
13. American Thoracic Society. Standardization of Spirometry, 1994 Update. American Thoracic Society. Am J Respir Crit Care Med 1995;152:1107-1136
14. Harris RA, Nishiyama SK, Wray DW, Richardson RS. Ultrasound assessment of flowmediated
dilation. Hypertension 2010;55:1075-1085
15. Yeboah J, Folsom AR, Burke GL, et al. Predictive value of brachial flow-mediated dilation for incident cardiovascular events in a population-based study: the multi-ethnic study of atherosclerosis. Circulation 2009;120:502-509 16. Yeboah J, Crouse JR, Hsu FC, Burke GL, Herrington DM. Brachial flow-mediated dilation predicts incident cardiovascular events in older adults: the Cardiovascular Health
Study. Circulation 2007;115:2390-2397
17. Fraser KL, Tullis DE, Sasson Z, et al. Pulmonary hypertension and cardiac function in
adult cystic fibrosis: role of hypoxemia. Chest 1999;115:1321-1328
18. Perrin FM, Serino W. Ischaemic heart disease--a new issue in cystic fibrosis? J R Soc
Med 2010;103 Suppl 1:S44-48
19. Robert R, Thoreau V, Norez C, et al. Regulation of the cystic fibrosis transmembrane
conductance regulator channel by beta-adrenergic agonists and vasoactive intestinal peptide in rat smooth muscle cells and its role in vasorelaxation. J Biol Chem 2004;279:21160-21168
20. Michoud MC, Robert R, Hassan M, et al. Role of the cystic fibrosis transmembrane
conductance channel in human airway smooth muscle. Am J Respir Cell Mol Biol
2009;40:217-222
21. Tousson A, Van Tine BA, Naren AP, Shaw GM, Schwiebert LM. Characterization of
CFTR expression and chloride channel activity in human endothelia. Am J Physiol
1998;275:C1555-1564
22. McKone EF, Goss CH, Aitken ML. CFTR genotype as a predictor of prognosis in cystic fibrosis. Chest 2006;130:1441-1447
23. Wood LG, Fitzgerald DA, Gibson PG, et al. Oxidative stress in cystic fibrosis: dietary and metabolic factors. J Am Coll Nutr 2001;20:157-165
24. Elizur A, Cannon CL, Ferkol TW. Airway inflammation in cystic fibrosis. Chest 2008;133:489-495
25. Acevedo M, Arnaiz P, Barja S, et al. [Relationship of C-reactive protein to adiposity, cardiovascular risk factors and subclinical atherosclerosis in healthy children]. Rev Esp Cardiol 2007;60:1051-1058
26. Ridker PM, Cook N. Clinical usefulness of very high and very low levels of C-reactive protein across the full range of Framingham Risk Scores. Circulation 2004;109:1955- 1959
27. Holmes MV, Jiang B, McNeill K, et al. Paradoxical association of C-reactive protein with endothelial function in rheumatoid arthritis. PLoS One 2010;5:e10242
28. Barr RG, Mesia-Vela S, Austin JH, et al. Impaired Flow-mediated Dilation is Associated with Low Pulmonary Function and Emphysema in Ex-smokers. Am J Respir Crit Care Med 2007;176:1200-1207
29. Eickhoff P, Valipour A, Kiss D, et al. Determinants of systemic vascular function in patients with stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008;178:1211-1218
30. Moro L, Pedone C, Scarlata S, et al. Endothelial dysfunction in chronic obstructive pulmonary disease. Angiology 2008;59:357-364
31. Orenstein DM, Franklin BA, Doershuk CF, et al. Exercise conditioning and cardiopulmonary fitness in cystic fibrosis. The effects of a three-month supervised running program. Chest 1981;80:392-398
32. Salh W, Bilton D, Dodd M, Webb AK. Effect of exercise and physiotherapy in aiding sputum expectoration in adults with cystic fibrosis. Thorax 1989;44:1006-1008
33. Schneiderman-Walker J, Pollock SL, Corey M, et al. A randomized controlled trial of a 3-year home exercise program in cystic fibrosis. J Pediatr 2000;136:304-310
34. Huang B, Brennan KM, Budinger TF, Maltz JS. Assessment of endothelial function in the radial artery using inhaled albuterol. Conf Proc IEEE Eng Med Biol Soc
2007;2007:3629-3631
